<DOC>
	<DOC>NCT00553592</DOC>
	<brief_summary>To compare the efficacy of two dosages (600mg/day and 1200mg/day) of bicifadine SR with placebo for 14 weeks in reduction of chronic neuropathic patin (measured by a daily rating of pain intensity) associated with diabetic periperal neuropathy in adult outpatients. To compare the tolerability of two dosages of bicifadine SR with placebo in adult outpaitens treated for chronic neuropathic pain for 14 weeks associated with diabetic peripheral neuropathy.</brief_summary>
	<brief_title>Double Blind RCT of Bicifadine SR in Outpatients With Chronic Neuropathic Pain Associated With Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Diabetic Neuropathies</mesh_term>
	<criteria>Male or female, 18 years or older Diagnosis of type1 or type 2 noninsulin dependent diabetes mellitus Chronic bilateral pain due to diabetic neuropathy Pain for at least six months Primary pain is located in the feet Otherscontact site for information Symptoms of other painful conditions Presence of amputations other than toes Clinically significant psychiatric or other neurological disorder Use of certain medications Clinically important other diseases Pregnancy History of alcohol or narcotic abuse within two years Otherscontact site for information</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2007</verification_date>
</DOC>